1. Blair, D.C., Director, Joint Staff, Department of Defense, "Joint Staff Response to Draft Presidential Advisory Committee on Gulf War Veterans' Illnesses," DJSM-821-97, September 24, 1997.
2. Central Intelligence Agency and Department of Defense, "Modeling the Chemical Warfare Agent Release at the Khamisiyah Pit," September 4, 1997.
3. DeFraites, R., Preventive Medicine Staff Officer, Office of the Army Surgeon General, U.S. Army, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Washington, DC, September 4, 1996.
4. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, Department of Defense, introductory material to all case narratives; see for example "U.S. Marine Corps Minefield Breaching," July 30, 1997.
5. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, "U.S. Marine Corps Minefield Breaching," July 30, 1997.
6. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, "Al Jaber Air Base," September 25, 1997.
7. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, "Fox Vehicle Detections in an ASP/Orchard," September 25, 1997.
8. Department of Defense, Office of the Special Assistant for Gulf War Illnesses, "Comments to PAC Draft Special Report, Copy 8," September 24, 1997.
9. "Department of Defense Directive Number 6490.2: Joint Medical Surveillance," August 30, 1997.
10. Donahue, M.B., Deputy Chief of Staff, Department of Health and Human Services, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 24, 1997.
11. Duelfer, C., Deputy Executive Chairman, United Nations Special Commission on Iraq, transcript of a panel meeting of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, July 29, 1997.
12. Fahlsing, G.A., Product Manager, Nuclear, Biological, and Chemical Reconnaissance Systems, U.S. Army, "Analysis of Fox MM1 Tapes," memorandum for the Office of the Special Assistant for Gulf War Illnesses, March 3, 1997.
13. Feussner, J.R., Chair, Research Working Group, Persian Gulf Veterans Coordinating Board, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Alexandria, VA, September 4, 1997.
14. Friedman, M.A., Lead Deputy Commissioner, Food and Drug Administration, letter to E.D. Martin, Acting Assistant Secretary of Defense (Health Affairs), July 22, 1997.
15. General Accounting Office, "Defense Health Care: Medical Surveillance Improved Since Gulf War, but Mixed Results in Bosnia," GAO/NSIAD-97-136, May 1997.
16. Institute of Medicine, Health Consequences of Service During the Persian Gulf War: Initial Findings and Recommendations for Immediate Action (Washington, DC: National Academy Press, 1995).
17. Joseph S.C., Assistant Secretary of Defense (Health Affairs), Department of Defense, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Washington, DC, September 5, 1996.
18. Martin, E., Acting Assistant Secretary of Defense (Health Affairs), Department of Defense, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 22, 1997.
19. Parker, J.S., Assistant Army Surgeon General for Force Projection, U.S. Army, testimony before a panel of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Charleston, SC, May 7, 1997.
20. Parker, J.S., Assistant Army Surgeon General for Force Projection, U.S. Army, transcript of a panel meeting of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Buffalo, NY, July 29, 1997.
21. Persian Gulf Veterans' Coordinating Board, "The Persian Gulf Veterans Coordinating Board Action Plan with Respect to the Findings and Recommendations of the Presidential Advisory Committee on Gulf War Veterans' Illnesses Final Report," March 7, 1997.
22. Presidential Advisory Committee on Gulf War Veterans' Illnesses, Interim Report (Washington, DC: U.S. Government Printing Office, February 1996).
23. Presidential Advisory Committee on Gulf War Veterans' Illnesses, Final Report (Washington, DC: U.S. Government Printing Office, December 1996).
24. Presidential Advisory Committee on Gulf War Veterans' Illnesses, " Supplemental Letter Report," Washington, DC, April 30, 1997.
25. Resta, J., Deployment Environmental Exposure Surveillance Program Manager, Center for Health Promotion and Preventive Medicine, U.S. Army, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Washington, DC, September 4, 1996.
26. Rostker, B., Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses, Department of Defense, transcript of a meeting of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Salt Lake City, UT, March 18, 1997.
27. Rostker, B., Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses, Department of Defense, transcript of a press briefing, May 1, 1997.
28. Rostker, B., Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses, Department of Defense, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 5, 1997.
29. Rostker, B., Special Assistant to the Deputy Secretary of Defense for Gulf War Illnesses, Department of Defense, correspondence to the Presidential Advisory Committee on Gulf War Veterans' Illnesses, September 24, 1997.
30. Stern, R.A., Physical Scientist, Chemical and Biological Defense Command, U.S. Army, transcript of a panel meeting of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Charleston, SC, May 7, 1997.
31. Trump, D., Director, Military Public Health, Office of the Assistant Secretary of Defense (Health Affairs), Department of Defense, testimony before a panel of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Buffalo, NY, July 29, 1997.
32. Vigus, R.A., Chemical Engineer, Chemical and Biological Defense Command, U.S. Army, transcript of a panel meeting of the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Charleston, SC, May 7, 1997.
33. Walpole, R., Special Assistant to the Director of Central Intelligence for Persian Gulf War Illnesses Issues, Central Intelligence Agency, testimony before the Presidential Advisory Committee on Gulf War Veterans' Illnesses, Alexandria, VA, September 4, 1997.